Dipyridamole echocardiography stress hypertensive patients Targets tools Arterial hypertension reduction coronary flow reserve several mechanisms exclusive coronary artery disease ventricular hypertrophy microvascular disease different targets arterial hypertension different diagnostic markers transient dyssynergy two-dimensional echocardiography dipyridamole infusion marker coronary disease reliable normotensive hypertensive individuals contrary dipyridamole-induced ST segment depression hypertensive patients coronary disease absent ischemiclike electrocardiographic response ventricular hypertrophy ventricular mass normal dipyridamole-induced ST segment depression impaired coronary flow response pacing consistent microvascular disease Whether silent electrocardiographic changes diagnostic noises misleading false positive response important clinical marker early myocardial damage pivotal though unanswered question 